Last deal

$1.7M

Amount

Series D

Stage

27.12.2018

Date

7

all rounds

$8.8M

Total amount

General

About Company
Somna Therapeutics improves quality of life for LPR/EERD sufferers with non-invasive Reza Band™, UES Assist Device.

Industry

Sector :

Subsector :

founded date

01.03.2012

Number of employees

Company Type

For Profit

Last funding type

Series D

IPO status

Private

Description

Founded in 2012 in partnership with the Medical College of Wisconsin, Somna Therapeutics is working on optimizing the design of their product and completing clinical trials to obtain FDA clearance. Once cleared, they plan to sell to hospitals, physician clinics, and home health care, aiming to help millions of people affected by these conditions.
Contacts

Phone number

Social url